Remote Hypertension Monitoring Program Successful During Pandemic

THURSDAY, March 30, 2023 (HealthDay News) -- A remote clinical management program successfully delivered significant improvements in blood pressure (BP) control during the pandemic, according to a study published online March 13 in the Journal of the American Heart Association.
Simin Gharib Lee, M.D., from Brigham and Women’s Hospital in Boston, and colleagues assessed the pandemic's impact on an existing remote hypertension management program's effectiveness and adaptability. The analysis included 1,256 patients (605 enrolled in the six months before the pandemic shutdown in March 2020 and 651 in the six months after).
The researchers found that overall, among enrolled patients with sustained hypertension, 51.1 percent reached BP goals. Rates of achieving goal BP improved to 94.6 percent during the pandemic, from 75.8 percent prepandemic. During the pandemic, mean baseline home BP was 141.7/81.9 mm Hg versus 139.8/82.2 prepandemic, and it fell ~16/9 mm Hg in both periods. During the pandemic, maintenance was achieved earlier (median 11.8 versus 19.6 weeks). More frequent monthly calls (8.2 versus 3.1) and more monthly home BP recordings per patient (32.4 versus 18.9) were seen during the pandemic versus the prepandemic period.
"A remote clinical management program was successfully adapted and delivered significant improvements in BP control and increased home BP monitoring despite a nationally observed disruption of traditional hypertension care," the authors write. "Such programs have the potential to transform hypertension management and care delivery."
Related Posts
Train Wheels Send Unhealthy, ‘Ultrafine’ Metals Into Subway Air
THURSDAY, Dec. 15, 2022 (HealthDay News) -- Air pollution is plaguing the...
El respaldo social después de una estadía en la UCI es vital para la supervivencia de las personas mayores
MIÉRCOLES, 15 de septiembre de 2021 (HealthDay News) -- Los adultos mayores que...
Physical Activity Affects Flu, Pneumonia Mortality
TUESDAY, May 23, 2023 (HealthDay News) -- Aerobic activity, even below the...
New ALS Drug Approved in Canada While Still Under FDA Review
MONDAY, June 13, 2022 (HealthDay News) -- An experimental drug for the...